Hochman David P purchased $48K of OBIO
Hochman David P (See Remarks) purchased 10,000 shares of Orchestra BioMed Holdings, Inc. (OBIO) at $4.79 on 2026-09-03.
How this was made
The 30-second read
Why it matters
The disclosed purchase adds a modest amount to insider holdings, offering limited insight for traders.
Market read
Routine insider purchase with minimal market impact.
What to watch
Potential upcoming corporate actions or upcoming data releases not disclosed.
Background
Orchestra BioMed Holdings (OBIO) is a biotech firm listed on NASDAQ. Insider transactions are regularly reported via Form 4.
Ticker impact
Form 4 filing shows insider David Hochman purchased 10,000 shares for $47,900, increasing his stake to over 1 million shares.
Minimal upward pressure, unlikely to move the stock significantly.
Purchase size is modest relative to market cap and typical daily volume; insider already holds a large position.
Market effects
None; transaction is company-specific.
None; limited to the issuer.
None
Counterpoint
The purchase could signal confidence, but size is too small to be meaningful.
Key entities
- CompanyOrchestra BioMed Holdings, Inc.
NASDAQ-listed biotech company.
- InsiderDavid P. Hochman
Officer and director of OBIO.